Accusative case

Cutter Law PC Announces $12.95 Million Settlement in Whistleblower Case Against Biotronik Alleging Kickbacks to Doctors

Retrieved on: 
Thursday, July 28, 2022

Cutter Law PC announces that the international medical device company, Biotronik, Inc., has agreed to pay more than $12.95 million to the United States and various States to resolve claims that Biotronik unlawfully paid kickbacks to physicians.

Key Points: 
  • Cutter Law PC announces that the international medical device company, Biotronik, Inc., has agreed to pay more than $12.95 million to the United States and various States to resolve claims that Biotronik unlawfully paid kickbacks to physicians.
  • 18-cv-01391, was brought by two former Biotronik employees and whistleblowers who are clients of Cutter Law PC.
  • A settlement has subsequently been negotiated to resolve the claims of the United States and several states in exchange for a $12.95 million payment by Biotronik.
  • The whistleblowers were represented in the False Claims Act suit by John R. Parker, Jr. and his partner Brooks Cutter , founding member of Cutter Law PC.

BIOGEN INC. AGREES TO PAY $900 MILLION TO RESOLVE WHISTLEBLOWER CLAIM REGARDING PAYMENT OF UNLAWFUL KICKBACKS

Retrieved on: 
Wednesday, July 20, 2022

We believe this is the largest False Claims Act recovery secured by a whistleblower without United States intervention.

Key Points: 
  • We believe this is the largest False Claims Act recovery secured by a whistleblower without United States intervention.
  • Mr. Bawduniak had reported his concerns to Biogen's compliance department, which had not taken any action.
  • In 1996, he brought an action on behalf of a whistleblower alleging that off-label promotion of the drug Neurontin defrauded the United States.
  • That case was resolved in 2004 when Pfizer, Inc. agreed to pay $430 million in civil fines and criminal penalties.

CDNA 4-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firm’s Attorneys, Application Deadline Approaching in Securities Fraud Class Action

Retrieved on: 
Monday, July 18, 2022

SAN FRANCISCO, July 18, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, July 18, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now .
  • CareDx, Inc. (CDNA) Securities Fraud Class Action:
    The complaint alleges that throughout the Class Period, CareDx reported growing revenue and strong demand in the Companys testing services segment.
  • If you invested in CareDx and have significant losses, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman .
  • Hagens Berman is a global plaintiffs rights complex litigation law firm focusing on corporate accountability through class-action law.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firm’s Attorneys, July 22nd Deadline Approaching in Securities Class Action

Retrieved on: 
Monday, July 11, 2022

SAN FRANCISCO, July 11, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, July 11, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now .
  • CareDx, Inc. (CDNA) Securities Fraud Class Action:
    The complaint alleges that throughout the Class Period, CareDx reported growing revenue and strong demand in the Companys testing services segment.
  • If you invested in CareDx and have significant losses, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman .
  • Hagens Berman is a global plaintiffs rights complex litigation law firm focusing on corporate accountability through class-action law.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firm’s Attorneys, Deadline Approaching in Securities Fraud Class Action

Retrieved on: 
Tuesday, July 5, 2022

SAN FRANCISCO, July 05, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, July 05, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now .
  • CareDx, Inc. (CDNA) Securities Fraud Class Action:
    The complaint alleges that throughout the Class Period, CareDx reported growing revenue and strong demand in the Companys testing services segment.
  • If you invested in CareDx and have significant losses, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman .
  • Hagens Berman is a global plaintiffs rights complex litigation law firm focusing on corporate accountability through class-action law.

CDNA DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending

Retrieved on: 
Wednesday, June 29, 2022

CareDx, Inc. (CDNA) Securities Fraud Class Action:

Key Points: 
  • CareDx, Inc. (CDNA) Securities Fraud Class Action:
    The complaint alleges that throughout the Class Period, CareDx reported growing revenue and strong demand in the Companys testing services segment.
  • Finally, on May 5, 2022, Defendants reported testing service revenue that fell well short of analysts expectations and deteriorating average sales prices.
  • If you invested in CareDx and have significant losses, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman .
  • Hagens Berman is a global plaintiffs rights complex litigation law firm focusing on corporate accountability through class-action law.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firm’s Attorneys, Deadline Approaching in Securities Fraud Class Action

Retrieved on: 
Thursday, June 23, 2022

SAN FRANCISCO, June 23, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, June 23, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now .
  • CareDx, Inc. (CDNA) Securities Fraud Class Action:
    The complaint alleges that throughout the Class Period, CareDx reported growing revenue and strong demand in the Companys testing services segment.
  • If you invested in CareDx and have significant losses, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman .
  • Hagens Berman is a global plaintiffs rights complex litigation law firm focusing on corporate accountability through class-action law.

CDNA DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending

Retrieved on: 
Monday, June 13, 2022

SAN FRANCISCO, June 13, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, June 13, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now .
  • CareDx, Inc. (CDNA) Securities Fraud Class Action:
    The complaint alleges that throughout the Class Period, CareDx reported growing revenue and strong demand in the Companys testing services segment.
  • If you invested in CareDx and have significant losses, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman .
  • Hagens Berman is a global plaintiffs rights complex litigation law firm focusing on corporate accountability through class-action law.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed

Retrieved on: 
Monday, June 6, 2022

SAN FRANCISCO, June 06, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, June 06, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now .
  • CareDx, Inc. (CDNA) Securities Fraud Class Action:
    The complaint alleges that throughout the Class Period, CareDx reported growing revenue and strong demand in the Companys testing services segment.
  • If you invested in CareDx and have significant losses, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman .
  • Hagens Berman is a global plaintiffs rights complex litigation law firm focusing on corporate accountability through class-action law.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed

Retrieved on: 
Tuesday, May 31, 2022

SAN FRANCISCO, May 31, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now .

Key Points: 
  • SAN FRANCISCO, May 31, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges CareDx, Inc. (NASDAQ: CDNA) investors to with significant losses to submit your losses now .
  • CareDx, Inc. (CDNA) Securities Fraud Class Action:
    The complaint alleges that throughout the Class Period, CareDx reported growing revenue and strong demand in the Companys testing services segment.
  • If you invested in CareDx and have significant losses, or have knowledge that may assist the firms investigation, click here to discuss your legal rights with Hagens Berman .
  • Hagens Berman is a global plaintiffs rights complex litigation law firm focusing on corporate accountability through class-action law.